Location: Home
  • search
  • go
  • Relate News
  • 9/17/2008Upcoming Event: Cardiometabolic Risk Factors and Clinical Outcomes in ...
  • 9/17/2008Survey shows fast growth and characteristics of Chinese diabetes marke...
  • 9/17/2008In-depth review of Shanghai hospital drug sales in 2007
  • 9/17/2008Founder Group acquires Wuhan National Medicine Group
  • 9/17/2008FDA issues import alert on 30 generic drugs from Ranbaxy
  • 9/17/2008Chinese Pre-clinical Safety Data: Is the FDA ready?
  • 9/16/2008Iressa recommended as a front line therapy for lung cancer of non-smok...
  • 9/16/2008China and U.S. reach agreements on healthcare and API products
  • 9/16/2008China kicks off research initiative targeting key epidemics
  • 9/16/2008Bayer Acquires Direvo Biotech
  • 9/16/2008Upcoming Event: US FDA Regulatory Compliance Workshop
  • 9/12/2008Oculus launches topical wound drug Dermacyn in China
  • 9/12/2008Simere promotes three senior executives
  • 9/12/2008Amendment to China''s Patent Law Will Impact Pharmaceutical Companies ...
  • 9/12/2008GlaxoSmithKline forms GSK Oncology
  • 9/12/2008MedImmune licenses autoimmune disease drug from SBI Biotech
  • 9/12/2008Upcoming Event - 2nd Annual International Congress World Cancer Confer...
  • 9/11/2008China to issue draft healthcare reform plan for public comments
  • 9/11/2008Shanghai to introduce zero drug sales margin policy in all suburban vi...
  • 9/11/2008China may usurp India''s pharma edge before long
  • 9/11/2008Xel Pharma completes of prototype Huperzine A transdermal patch
  • 9/11/2008Quintiles to expand in Asia Pacific
  • 9/11/2008GSK enters strategic alliance with Cellzome
  • 9/9/2008Speculation: Pfizer may seek to take over Bayer
  • 9/9/2008Newly approved SFDA responsibilities and internal structure (Updated)
  • 9/9/2008Review of leading 100 Chinese pharmaceutical distributors in 2007
  • 9/9/2008Chinese government plans to transform its pharma industry into an inno...
  • 9/9/2008Merck KGaA to step up pharma sector investment in China
  • 9/9/2008Tianjin Tianyao Pharma to produce androstenedione with new process and...
  • 9/9/2008New report: Chinese hepatitis C market to double by 2012
  • Page:713/798 Total number of articles:23936: [First][<<] [711] [712] [713] [714] [715] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group